Evonik-CU-CS_PR-Closure Project Beryx
Press Release

November 03, 2025

Evonik divests betaines business in Indonesia

On 31 October 2025, Evonik and joint venture partner PT Sumi Asih closed the purchase with Aekyung Chemical Co, Ltd, one of the largest chemical companies in South Korea.

  • Sale of site in Bekasi, Indonesia
  • Next step in transformation of Care Solutions portfolio
  • Focus on sustainable specialty chemicals

Evonik is advancing its transformation into a sustainable specialties provider by divesting its betaines business in Bekasi, Indonesia. On 31 October 2025, Evonik and its joint venture partner PT Sumi Asih closed the purchase with Aekyung Chemical Co, Ltd, one of the largest chemical companies in South Korea. The transaction comprises 100 percent of the PT Evonik Sumi Asih joint venture including its management, operations, assets and around 60 employees.

“Our site in Bekasi has played a key role in expanding our life sciences businesses across the Asia-Pacific region,” said Ute Schick, head of the Care Solutions business line. “As our focus shifts toward sustainable specialties – such as our investments in biosurfactants – this divestment aligns with our strategic direction.”

Evonik has long held a leading global position in the betaines market. However, over the past 15 years, Evonik has been following a strategy of bridging sustainability and performance through tailored, eco-friendly solutions for the personal care and cleaning industries. Adjusting the portfolio of the Care Solutions business line gives Evonik further opportunities for investments in sustainable specialties, especially within high growth areas such as cosmetic active ingredients.

In August 2022, Evonik divested its betaines business in Hopewell, Virginia in the U.S. This followed the sale of its betaines business in Milton Keynes in the UK in August 2020 and the consolidation of its European betaine operation in Essen, Germany. The divestment in Bekasi is the latest step in Evonik’s strategic shift away from assets and activities relating to its global betaine operations. Evonik will continue its betaines businesses in Europe and Latin America.

Betaines are amphoteric surfactants, which are used as ingredients in the formulation of shampoos, hair conditioners and skin care products for the personal care industry and in a wide range of other consumer applications.

Evonik’s Bekasi site is located around 20 km east of Jakarta and produces betaines and esters. As a strategically located manufacturing operation, the site is well suited to serve major markets in Southeast Asia and beyond.

Evonik: Leading beyond chemistry

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €15.2 billion and earnings (adjusted EBITDA) of €2.1 billion in 2024. The common motivation of the approximately 32,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.